Polymorphic HLA-C receptors balance the functional characteristics of KIR haplotypes

Journal of Immunology

Volumn 195, Issue 7, 2015, Pages 3160-3170

  Hilton, Hugo G ^a   Guethlein, Lisbeth A ^a   Goyos, Ana ^a   Nemat Gorgani, Neda ^a   Bushnell, David A ^a   Norman, Paul J ^a   Parham, Peter ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA C ANTIGEN; HLA C ANTIGEN RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN KIR2DL1; PROTEIN KIR2DL2; PROTEIN KIR2DL3; PROTEIN KIR2DS1; UNCLASSIFIED DRUG; EPITOPE; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; KIR2DL1 PROTEIN, HUMAN; KIR2DL2 PROTEIN, HUMAN; KIR2DL3 PROTEIN, HUMAN; KIR2DS1 PROTEIN, HUMAN; PROTEIN BINDING;

ALLOTYPE; ARTICLE; CELL SURFACE; CELLULAR IMMUNITY; CLADISTICS; CONTROLLED STUDY; GENE FUNCTION; GENE STRUCTURE; HAPLOTYPE; HUMAN; HUMAN CELL; IMMUNOREGULATION; LIGAND BINDING; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; PHYLOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; RECEPTOR UPREGULATION; AMINO ACID SEQUENCE; BINDING SITE; GENE FREQUENCY; GENETICS; HELA CELL LINE; IMMUNOLOGY; NATURAL KILLER CELL; PROTEIN TERTIARY STRUCTURE; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR CELL LINE;

AMINO ACID SEQUENCE; BINDING SITES; CELL LINE, TUMOR; EPITOPES; GENE FREQUENCY; HAPLOTYPES; HELA CELLS; HLA-C ANTIGENS; HUMANS; KILLER CELLS, NATURAL; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, KIR; RECEPTORS, KIR2DL1; RECEPTORS, KIR2DL2; RECEPTORS, KIR2DL3;

EID: 84942465668     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501358     Document Type: Article

References (53)

1. Lanier, L. L. 2008. Evolutionary struggles between NK cells and viruses. Nat. Rev. Immunol. 8: 259-268.
2. Diefenbach, A., and D. H. Raulet. 2002. The innate immune response to tumors and its role in the induction of T-cell immunity. Immunol. Rev. 188: 9-21.
3. Parham, P., and A. Moffett. 2013. Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat. Rev. Immunol. 13: 133-144.
4. Lanier, L. L. 2008. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 9: 495-502.
5. Parham, P., L. Abi-Rached, L. Matevosyan, A. K. Moesta, P. J. Norman, A. M. Older Aguilar, and L. A. Guethlein. 2010. Primate-specific regulation of natural killer cells. J. Med. Primatol. 39: 194-212.
6. Alter, G., D. Heckerman, A. Schneidewind, L. Fadda, C. M. Kadie, J. M. Carlson, C. Oniangue-Ndza, M. Martin, B. Li, S. I. Khakoo, et al. 2011. HIV-1 adaptation to NK-cell-mediated immune pressure. Nature 476: 96-100.
7. Khakoo, S. I., C. L. Thio, M. P. Martin, C. R. Brooks, X. Gao, J. Astemborski, J. Cheng, J. J. Goedert, D. Vlahov, M. Hilgartner, et al. 2004. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305: 872-874.
8. Wauquier, N., C. Padilla, P. Becquart, E. Leroy, and V. Vieillard. 2010. Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. Immunogenetics 62: 767-771.
9. Łuszczek, W., M. Manczak, M. Cisło, P. Nockowski, A. Wisniewski, M. Jasek, and P. Kusnierczyk. 2004. Gene for the activating natural killer cell receptor, KIR2DS1, is associated with susceptibility to psoriasis vulgaris. Hum. Immunol. 65: 758-766.
10. Suzuki, Y., Y. Hamamoto, Y. Ogasawara, K. Ishikawa, Y. Yoshikawa, T. Sasazuki, and M. Muto. 2004. Genetic polymorphisms of killer cell immunoglobulin-like receptors are associated with susceptibility to psoriasis vulgaris. J. Invest. Dermatol. 122: 1133-1136.
11. van der Slik, A. R., B. P. Koeleman, W. Verduijn, G. J. Bruining, B. O. Roep, and M. J. Giphart. 2003. KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes 52: 2639-2642.
12. Cooley, S., D. J. Weisdorf, L. A. Guethlein, J. P. Klein, T. Wang, C. T. Le, S. G. Marsh, D. Geraghty, S. Spellman, M. D. Haagenson, et al. 2010. Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood 116: 2411-2419.
13. Cooley, S., D. J. Weisdorf, L. A. Guethlein, J. P. Klein, T. Wang, S. G. Marsh, S. Spellman, M. D. Haagenson, K. Saeturn, M. Ladner, et al. 2014. Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia. J. Immunol. 192: 4592-4600.
14. Hiby, S. E., J. J. Walker, K. M. O'shaughnessy, C. W. Redman, M. Carrington, J. Trowsdale, and A. Moffett. 2004. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 200: 957-965.
15. Nakimuli, A., O. Chazara, S. E. Hiby, L. Farrell, S. Tukwasibwe, J. Jayaraman, J. A. Traherne, J. Trowsdale, F. Colucci, E. Lougee, et al. 2015. A KIR B centromeric region present in Africans but not Europeans protects pregnant women from pre-eclampsia. Proc. Natl. Acad. Sci. USA 112: 845-850.
16. Kovats, S., E. K. Main, C. Librach, M. Stubblebine, S. J. Fisher, and R. DeMars. 1990. A class I antigen, HLA-G, expressed in human trophoblasts. Science 248: 220-223.
17. Rajagopalan, S., and E. O. Long. 1999. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J. Exp. Med. 189: 1093-1100.
18. Yang, Y., W. Chu, D. E. Geraghty, and J. S. Hunt. 1996. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-g. J. Immunol. 156: 4224-4231.
19. Winter, C. C., and E. O. Long. 1997. A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. J. Immunol. 158: 4026-4028.
20. Moesta, A. K., T. Graef, L. Abi-Rached, A. M. Older Aguilar, L. A. Guethlein, and P. Parham. 2010. Humans differ from other hominids in lacking an activating NK cell receptor that recognizes the C1 epitope of MHC class I. J. Immunol. 185: 4233-4237.
21. Moesta, A. K., P. J. Norman, M. Yawata, N. Yawata, M. Gleimer, and P. Parham. 2008. Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. J. Immunol. 180: 3969-3979.
22. Barrow, A. D., and J. Trowsdale. 2008. The extended human leukocyte receptor complex: diverse ways of modulating immune responses. Immunol. Rev. 224: 98-123.
23. Trowsdale, J., R. Barten, A. Haude, C. A. Stewart, S. Beck, and M. J. Wilson. 2001. The genomic context of natural killer receptor extended gene families. Immunol. Rev. 181: 20-38.
24. Wilson, M. J., M. Torkar, A. Haude, S. Milne, T. Jones, D. Sheer, S. Beck, and J. Trowsdale. 2000. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc. Natl. Acad. Sci. USA 97: 4778-4783.
25. Pyo, C. W., L. A. Guethlein, Q. Vu, R. Wang, L. Abi-Rached, P. J. Norman, S. G. Marsh, J. S. Miller, P. Parham, and D. E. Geraghty. 2010. Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus. PLoS One 5: e15115.
26. Abi-Rached, L., A. K. Moesta, R. Rajalingam, L. A. Guethlein, and P. Parham. 2010. Human-specific evolution and adaptation led to major qualitative differences in the variable receptors of human and chimpanzee natural killer cells. PLoS Genet. 6: e1001192.
27. Bimber, B. N., A. J. Moreland, R. W. Wiseman, A. L. Hughes, and D. H. O'Connor. 2008. Complete characterization of killer Ig-like receptor (KIR) haplotypes in Mauritian cynomolgus macaques: novel insights into nonhuman primate KIR gene content and organization. J. Immunol. 181: 6301-6308.
28. Uhrberg, M., N. M. Valiante, B. P. Shum, H. G. Shilling, K. Lienert-Weidenbach, B. Corliss, D. Tyan, L. L. Lanier, and P. Parham. 1997. Human diversity in killer cell inhibitory receptor genes. Immunity 7: 753-763.
29. Gendzekhadze, K., P. J. Norman, L. Abi-Rached, T. Graef, A. K. Moesta, Z. Layrisse, and P. Parham. 2009. Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands. Proc. Natl. Acad. Sci. USA 106: 18692-18697.
30. Shilling, H. G., L. A. Guethlein, N. W. Cheng, C. M. Gardiner, R. Rodriguez, D. Tyan, and P. Parham. 2002. Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J. Immunol. 168: 2307-2315.
31. Bari, R., T. Bell, W. H. Leung, Q. P. Vong, W. K. Chan, N. Das Gupta, M. Holladay, B. Rooney, and W. Leung. 2009. Significant functional heterogeneity among KIR2DL1 alleles and a pivotal role of arginine 245. Blood 114: 5182-5190.
32. Winter, C. C., J. E. Gumperz, P. Parham, E. O. Long, and N. Wagtmann. 1998. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J. Immunol. 161: 571-577.
33. Yawata, M., N. Yawata, M. Draghi, F. Partheniou, A. M. Little, and P. Parham. 2008. MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response. Blood 112: 2369-2380.
34. Saitou, N., and M. Nei. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4: 406-425.
35. Tamura, K., G. Stecher, D. Peterson, A. Filipski, and S. Kumar. 2013. MEGA6: molecular Evolutionary Genetics Analysis version 6.0. Mol. Biol. Evol. 30: 2725-2729.
36. Hilton, H. G., A. K. Moesta, L. A. Guethlein, J. Blokhuis, P. Parham, and P. J. Norman. 2015. The production of KIR-Fc fusion proteins and their use in a multiplex HLA class I binding assay. J. Immunol. Methods S0022-1759(15) 30014-4 10.1016/j.jim.2015.06.012.
37. Robinson, J., J. A. Halliwell, H. McWilliam, R. Lopez, and S. G. Marsh. 2013. IPD-the Immuno Polymorphism Database. Nucleic Acids Res. 41: D1234-D1240.
38. Hou, L., M. Chen, B. Jiang, D. Wu, J. Ng, and C. K. Hurley. 2010. Thirty allelelevel haplotypes centered around KIR2DL5 define the diversity in an African American population. Immunogenetics 62: 491-498.
39. Hou, L., M. Chen, J. Ng, and C. K. Hurley. 2012. Conserved KIR allele-level haplotypes are altered by microvariation in individuals with European ancestry. Genes Immun. 13: 47-58.
40. Norman, P. J., J. A. Hollenbach, N. Nemat-Gorgani, L. A. Guethlein, H. G. Hilton, M. J. Pando, K. A. Koram, E. M. Riley, L. Abi-Rached, and P. Parham. 2013. Co-evolution of human leukocyte antigen (HLA) class I ligands with killer-cell immunoglobulin-like receptors (KIR) in a genetically diverse population of sub-Saharan Africans. PLoS Genet. 9: e1003938.
41. Vierra-Green, C., D. Roe, L. Hou, C. K. Hurley, R. Rajalingam, E. Reed, T. Lebedeva, N. Yu, M. Stewart, H. Noreen, et al. 2012. Allele-level haplotype frequencies and pairwise linkage disequilibrium for 14 KIR loci in 506 European-American individuals. PLoS One 7: e47491.
42. Middleton, D., A. Meenagh, and P. A. Gourraud. 2007. KIR haplotype content at the allele level in 77 Northern Irish families. Immunogenetics 59: 145-158.
43. Nemat-Gorgani, N., H. A. Edinur, J. A. Hollenbach, J. A. Traherne, P. P. Dunn, G. K. Chambers, P. Parham, and P. J. Norman. 2014. KIR diversity in Maori and Polynesians: populations in which HLA-B is not a significant KIR ligand. Immunogenetics 66: 597-611.
44. Hilton, H. G., P. J. Norman, N. Nemat-Gorgani, A. Goyos, J. A. Hollenbach, B. M. Henn, C. R. Gignoux, L. A. Guethlein, and P. Parham. 2015. Loss and gain of natural killer cell receptor function in an African hunter-gatherer population. PLoS Genet. 11: e1005439.
45. Lanier, L. L., B. C. Corliss, J. Wu, C. Leong, and J. H. Phillips. 1998. Immunoreceptor DAP12 bearing a tyrosine based activation motif is involved in activating NK cells. Nature 391: 703-707.
46. Burshtyn, D. N., A. M. Scharenberg, N. Wagtmann, S. Rajagopalan, K. Berrada, T. Yi, J. P. Kinet, and E. O. Long. 1996. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 4: 77-85.
47. VandenBussche, C. J., S. Dakshanamurthy, P. E. Posch, and C. K. Hurley. 2006. A single polymorphism disrupts the killer Ig-like receptor 2DL2/2DL3 D1 domain. J. Immunol. 177: 5347-5357.
48. Fan, Q. R., L. Mosyak, C. C.Winter, N.Wagtmann, E. O. Long, and D. C. Wiley. 1997. Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors. Nature 389: 96-100.
49. Boyington, J. C., S. A. Motyka, P. Schuck, A. G. Brooks, and P. D. Sun. 2000. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 405: 537-543.
50. Frazier, W. R., N. Steiner, L. Hou, S. Dakshanamurthy, and C. K. Hurley. 2013. Allelic variation in KIR2DL3 generates a KIR2DL2-like receptor with increased binding to its HLA-C ligand. J. Immunol. 190: 6198-6208.
51. Hilton, H. G., L. Vago, A. M. Older Aguilar, A. K.Moesta, T. Graef, L. Abi-Rached, P. J. Norman, L. A. Guethlein, K. Fleischhauer, and P. Parham. 2012. Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3. J. Immunol. 189: 1418-1430.
52. Wilson, M. J., M. Torkar, and J. Trowsdale. 1997. Genomic organization of a human killer cell inhibitory receptor gene. Tissue Antigens 49: 574-579.
53. Uhrberg, M., P. Parham, and P. Wernet. 2002. Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics 54: 221-229.